Evaluation of different techniques in the diagnosis of Toxoplasma encephalitis

References

1. Luft B. J., Remington J. S. Toxoplasmic encephalitis in AIDS. Clin Infect Dis 1992; 15:211–222
   [Google Scholar]
2. Wong S. Y., Israelski D. M., Remington J. S. AIDS-associated toxoplasmosis. In Sande M. A., Volverding P. A. (eds) The medical management of AIDS 4th edn Philadelphia: WB Sanders; 1995460–493
   [Google Scholar]
3. Zangerle R., Allerberger F., Pohl P., Fritsch P., Dierich M. P. High risk of developing toxoplasmic encephalitis in AIDS patients seropositive to Toxoplasma gondii. Med Microbiol Immunol 1991; 180:59–66
   [Google Scholar]
4. Porter S. B., Sande M. A. Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome. N Engl J Med 1992; 327:1643–1648
   [Google Scholar]
5. Joynson D. H. M., Payne R. A., Balfour A. H., Prestage E. S., Fleck D. G. Five commercial enzyme linked immunosorbent assay kits for toxoplasma specific IgM antibody. J Clin Pathol 1989; 42:653–657
   [Google Scholar]
6. Wilson M., Ware D. A., Walls K. W. Evaluation of commercial serodiagnostic kits for toxoplasmosis. J Clin Microbiol 1987; 25:2262–2265
   [Google Scholar]
7. Verhofstede C., Van Renterghem L., Plum J. Comparison of six commercial enzyme linked immunosorbent assays for detecting IgM antibodies against Toxoplasma gondii. J Clin Pathol 1989; 42:1285–1290
   [Google Scholar]
8. Del Bono V., Canessa A., Bruzzi P., Fiorelli M. A., Terragna A. Significance of specific immunoglobulin M in the chronological diagnosis of 38 cases of toxoplasmic lymphadenopathy. J Clin Microbiol 1989; 27:2133–2135
   [Google Scholar]
9. Holliman R. E., Raymond R., Renton N., Johnson J. D. The diagnosis of toxoplasmosis using IgG avidity. Epidemiol Infect 1994; 112:399–408
   [Google Scholar]
10. Lappalainen M., Koskela P., Koskiniemi M. Toxoplasmosis acquired during pregnancy: improved serodiagnosis based on avidity of IgG. J Infect Dis 1993; 167:691–697
    [Google Scholar]
11. Hoshino-Shimizu S., Mineo J. R., Camargo M. A. Lectin used in the purification process of Toxoplasma gondii tachyzoites. J Parasitol 1980; 66:989–991
    [Google Scholar]
12. Sambrook J., Fritsch E. F., Maniatis T. Molecular cloning - a laboratory manual. 2nd edn Cold Spring Harbor: NY Cold Spring Harbor Laboratory Press; 198912–13
    [Google Scholar]
13. van Rnapen F., Panggabean S. O., van Leusden J. Evaluation of laboratory diagnosis of toxoplasmosis by means of an ELISA-triple test. Detection of class specific IgG, IgM and circulating antigens. Anlonie van Leeuwenhoek 1986; 52:5–13
    [Google Scholar]
14. Turunen H. J. Detection of soluble antigens of Toxoplasma gondii by a four-layer modification of an enzyme immunoassay. J Clin Microbiol 1983; 17:768–773
    [Google Scholar]
15. Lindenschmidt E. G. Enzyme-linked inmunosorbent assay for detection of soluble Toxoplasma gondii antigen in acute-phase toxoplasmosis. Eur J Clin Microbiol 1985; 4:488–492
    [Google Scholar]
16. Burg J. L., Grover C. M., Pouletty P., Boothroyd J. C. Direct and sensitive detection of a pathogenic protozoan, Toxoplasma gondii, by polymerase chain reaction. J Clin Microbiol 1989; 27:1787–1792
    [Google Scholar]
17. Malloy D., Nauman R. K., Paxton H. Detection of Borrelia burgdorferi using the polymerase chain reaction. J Clin Microbiol 1990; 28:1089–1093
    [Google Scholar]
18. Derouin F., Thulliez P., Garin Y. J. [Value and limitations of toxoplasmosis serology in HIV patients.]. Pathol Biologie (Paris) 1991; 39:255–259
    [Google Scholar]
19. Zufferey J., Sugar A., Rudaz P., Bille J., Glauser M. P., Chave J. P. Prevalence of latent toxoplasmosis and serological diagnosis of active infection in HIV-positive patients. Eur J Microbiol Infect Dis 1993; 12:591–595
    [Google Scholar]
20. Jaqueti J., Nicolas D., Navarro Gallar F. [Persistence of IgA antibodies against Toxoplasma gondii with ELISA.]. Med Clin (Barcelona) 1994; 103:197
    [Google Scholar]
21. Patel B., Young Y., Duffy K., Tanner R. P., Johnson J., Holliman R. E. Immunoglobulin-A detection and the investigation of clinical toxoplasmosis. J Med Microbiol 1993; 38:286–292
    [Google Scholar]
22. Pinon J. M., Foudrinier F., Mougeot G. Evaluation of risk and diagnostic value of quantitative assays of anti-Toxoplasma gondii immunoglobulin A (IgA), IgE, and IgM and analytical study of specific IgG in immunodeficient patients. J Clin Microbiol 1995; 33:878–884
    [Google Scholar]
23. Holliman R. E. Serological study of the prevalence of toxoplasmosis in asymptomatic patients infected with human immunodeficiency virus. Epidemiol Infect 1990; 105:415–418
    [Google Scholar]
24. Grant I. H., Gold J. W. M., Rosenblum M., Niedzwiecki D., Armstrong D. Toxoplasma gondii serology in HIV-infected patients: the development of central nervous system toxoplasmosis in AIDS. AIDS 1990; 4:519–521
    [Google Scholar]
25. Dannemann B. R., Israelski D. M., Leoung G. S., McGraw T., Mills J., Remington J. S. Toxoplasma serology, parasitemia and antigenemia in patients at risk for toxoplasmic encephalitis. AIDS 1991; 5:1363–1365
    [Google Scholar]
26. Hassl A., Aspock H., Flamm H. Circulating antigen of Toxoplasma gondii in patients with AIDS: significance of detection and structural properties. Zentralbl Bakteriol Mikrobiol Hyg A 1988; 270:302–329
    [Google Scholar]
27. Candolfi E., Derouin F., Kien T. Detection of circulating antigens in immunocompromised patients during reactivation of chronic toxoplasmosis. Eur J Clin Microbiol 1987; 6:44–48
    [Google Scholar]
28. Letillois M. F., Laigle V., Santoro F., Micoud M., Chumpitazi B. F. F. Toxoplasma gondii surface antigen-1 in sera of HIV-infected patients as an indicator of reactivated toxoplasmosis. Eur J Clin Microbiol Infect Dis 1995; 14:899–903
    [Google Scholar]
29. Wastling J. M., Nicoll S., Buxton D. Comparison of two gene amplification methods for the detection of Toxoplasma gondii in experimentally infected sheep. J Med Microbiol 1993; 38:360–365
    [Google Scholar]
30. Gross U., Roggenkamp A., Janitschke K., Heesemann J. Improved sensitivity of the polymerase chain reaction for detection of Toxoplasma gondii in biological and human clinical specimens. Eur J Clin Microbiol Infect Dis 1992; 11:33–39
    [Google Scholar]
31. Cristina N., Pelloux H., Goulhot C., Brion J. P., Leclercq P., Ambroise Thomas P. T. I. Detection of Toxoplasma gondii in AIDS patients by the polymerase chain reaction. Infection 1993; 21:150–153
    [Google Scholar]
32. Ostergaard L., Nielsen A. K., Black F. T. DNA amplification on cerebrospinal fluid for diagnosis of cerebral toxoplasmosis among HIV-positive patients with signs or symptoms of neurological disease. Scand J Infect Dis 1993; 25:227–237
    [Google Scholar]
33. Schoondermark-van de Ven E., Galama J., Kraaijeveld C., van Druten J., Meuwissen J., Melchers W. Value of the polymerase chain reaction for the detection of Toxoplasma gondii in cerebrospinal fluid from patients with AIDS. Clin Infect Dis 1993; 16:661–666
    [Google Scholar]
34. Lebech M., Lebech A.-M., Nelsing S., Vuust J., Mathiesen J., Petersen E. Detection of Toxoplasma gondii DNA by polymerase chain reaction in cerebrospinal fluid from AIDS patients with cerebral toxoplasmosis. J Infect Dis 1992; 165:982–983
    [Google Scholar]
35. Novati R., Castagna A., Morsica G. Polymerase chain reaction for Toxoplasma gondii DNA in the cerebrospinal fluid of AIDS patients with focal brain lesions. AIDS 1994; 8:1691–1694
    [Google Scholar]